Health
New anti-cancer drug breakthrough for prostate cancer – Mirage News
Novel anti-cancer agents induce the degradation of the c-Met oncoprotein in the lysosome as demonstrated by confocal microscopy in tumour cells A new…
A new anti-cancer drug for prostate cancer overcomes the twin problems plaguing researchers for decades. It halts metastasis (tumour spread) and drug resistance.
Developed by Griffith University researcher Professor Des Richardson and colleagues from the University of Sydney, the drug known as DpC inhibits prostate specific antigen (PSA) as well as suppressing both androgen-dependent and independent arms of androgen receptor signalling.
“The current gold standard for prostate cancer treatment …
-
Business23 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News22 hours agoQueensland government to review greenhouse gas emission reduction targets
-
Noosa News23 hours agoYoung voices shape Sunshine Coast’s future
-
Noosa News21 hours agoBrisbane news live: Broken-down train causes peak-hour delays